Nanowear
Nanowear is transforming home-based cardiometabolic healthcare with its end-to-end FDA-approved cloth nanotechnology and AI diagnostics platform, SimpleSense. This system provides a full cardiometabolic assessment and continuous health picture by capturing over 85 medical-grade biomarkers directly from the skin. The technology empowers research and clinician teams with efficient, cost-effective endpoints, offering a user-friendly home-based patient experience. Nanowear's patented nanosensors and AI-enabled algorithms analyze terabytes of unique human data, allowing for continuous, time-synchronized monitoring that replaces up to eight diagnostic tools. This data streamlines communication between patients and healthcare teams, improving clinical trial efficiency and enabling better physician decision-making without the need for in-person visits.
Nanowear
Nanowear is transforming home-based cardiometabolic healthcare with its end-to-end FDA-approved cloth nanotechnology and AI diagnostics platform, SimpleSense. This system provides a full cardiometabolic assessment and continuous health picture by capturing over 85 medical-grade biomarkers directly from the skin. The technology empowers research and clinician teams with efficient, cost-effective endpoints, offering a user-friendly home-based patient experience. Nanowear's patented nanosensors and AI-enabled algorithms analyze terabytes of unique human data, allowing for continuous, time-synchronized monitoring that replaces up to eight diagnostic tools. This data streamlines communication between patients and healthcare teams, improving clinical trial efficiency and enabling better physician decision-making without the need for in-person visits.
TL;DR
Sector: Medtech / Biotechnology (wearable nanosensor diagnostics)
Core product: SimpleSense — cloth-based nanosensor wearable + AI diagnostics
Regulatory status: Multiple FDA 510(k) clearances
Founded: 2014
Notable investors: MAS Holdings; The Social+Capital Partnership; MedTech Innovator
Company Overview
Problem Domain
Remote patient monitoring, virtual care, clinical trial endpoints and cardiometabolic/cardiopulmonary diagnostics.
Founded
2014
Industry
Biotechnology
Tech Stack
Funding Track Record
1500000
Seed investment announced Sept 10, 2014
Crunchbase records indicate additional grant funding and two funding rounds